Treatment of hypertension as a risk factor in a prospective study

H L Thürmer1, P G Lund-Larsen, A Tverdal

  • 1National Health Screening Service, Oslo, Norway.

Insights

Blood pressure treatment in a real-world setting was linked to higher mortality rates. This study suggests treatment outcomes may be worse than in clinical trials, especially for those on medication.

Area of Science:

  • Cardiovascular epidemiology
  • Public health research
  • Clinical outcomes analysis

Background:

  • Blood pressure management is crucial for cardiovascular health.
  • Real-world effectiveness of hypertension treatment requires ongoing investigation.
  • Previous studies often focus on controlled clinical trial data.

Purpose of the Study:

  • To examine the association between blood pressure treatment, blood pressure levels, and mortality.
  • To compare mortality risks in individuals receiving blood pressure medication versus those not treated.
  • To investigate the relationship between blood pressure and mortality, considering cardiovascular risk factors.

Main Methods:

  • A 12-year follow-up study of a cardiovascular risk factor screening.
  • Inclusion of 33,154 men and 16,407 women aged 40-49 with complete blood pressure and treatment data.
  • Analysis of mortality from coronary heart disease, stroke, and all causes, stratified by treatment status and blood pressure levels.

Main Results:

  • Individuals on blood pressure medication showed significantly higher mortality from cardiovascular disease and all causes.
  • A J-shaped association between blood pressure and mortality was observed in the treated group.
  • Excess mortality was noted even after accounting for previous myocardial infarction or stroke.

Conclusions:

  • Blood pressure treatment in this population was associated with increased all-cause mortality.
  • Real-world treatment outcomes may be inferior to those reported in controlled clinical trials.
  • A J-shaped relationship between blood pressure and mortality exists for men on treatment.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...